한글목차

세계의 횡격막 페이싱 요법 시스템 시장 규모는 2024년에 77억 1,000만 달러에 달하며, 예측 기간에는 2030년까지 CAGR 4.06%로 인상적인 성장이 예측됩니다.

세계의 횡격막 페이싱 요법 시스템 시장은 호흡기 질환의 유병률 증가, 의료기기의 기술 발전, 특정 환자군의 대체요법으로 횡격막 페이싱에 대한 인식 증가 등의 요인으로 인해 최근 수년간 꾸준한 성장세를 보이고 있습니다. 예를 들어 유럽에서 호흡기 질환은 유럽 환경청 회원국의 사망 원인 중 3위를 차지하고 있습니다. 연간 약 42만 명이 호흡기 질환으로 사망하고 있으며, 그 중 60% 이상이 만성 호흡기 질환(CRD)과 관련이 있다(Eurostat, 2024a;WHO, 2024;IHME, 2024). 호흡기 질환으로 인한 사망률과 질병부담이 높은 국가가 있는 반면, 일관된 지역적 패턴은 확인되지 않았습니다.

시장 성장 촉진요인

호흡기질환의 유병률 상승

주요 시장이 해결해야 할 과제

높은 초기 비용

주요 시장 동향

디바이스 기술의 강화

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 횡격막 페이싱 요법 시스템 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품별(외막 페이스메이커, 횡격막 페이스메이커)
  • 용도별(척수 손상, 근위축성측색경화증, 기타)
  • 지역별
  • 기업별(2024)
• 제품 시장 맵
  • 제품별
  • 용도별
  • 지역별

제6장 북미의 횡격막 페이싱 요법 시스템 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 횡격막 페이싱 요법 시스템 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 횡격막 페이싱 요법 시스템 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 횡격막 페이싱 요법 시스템 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 횡격막 페이싱 요법 시스템 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• LUNGPACER MEDICAL INC.
• Avery Biomedical Devices, Inc.
• Synapse Biomedical Inc
• Astrotech Corp
• AstraZeneca PLC
• Novartis AG
• Boehringer Ingelheim
• Respironics Ltd
• Johnson & Johnson(Actelion)
• PneumRx, LLC

제15장 전략적 제안

제16장 조사회사 소개·면책사항

영문목차

Global Diaphragm Pacing Therapy System Market was valued at USD 7.71 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.06% through 2030. The Global Diaphragm Pacing Therapy System Market has witnessed steady growth in recent years, driven by factors such as the rising prevalence of respiratory disorders, technological advancements in medical devices, and increasing awareness about diaphragm pacing as an alternative therapy for certain patient populations. For instance, in Europe, respiratory disorders rank as the third leading cause of death in European Environment Agency member countries. Annually, nearly 420,000 deaths are attributed to respiratory diseases, with over 60% linked to Chronic Respiratory Diseases (CRDs) (Eurostat, 2024a; WHO, 2024; IHME, 2024). While certain countries experience higher mortality and disease burden from respiratory conditions, no consistent regional pattern has been identified.

Key Market Drivers

Rising Prevalence of Respiratory Disorders

The global healthcare landscape is witnessing a significant shift, with a concerning increase in the prevalence of respiratory disorders. These conditions can significantly impair an individual's ability to breathe, leading to a reduced quality of life and, in severe cases, life-threatening situations. However, amidst these challenges, there is a glimmer of hope for patients in the form of diaphragm pacing therapy systems. As the prevalence of respiratory disorders continues to rise, the diaphragm pacing therapy system market is poised for substantial growth. According to WHO, chronic obstructive pulmonary disease (COPD) claims over 3 million lives annually, silently impacting more than 380 million people worldwide. As the fourth leading cause of death globally, COPD has remained underrepresented in global health discussions, despite its profound effects on patients and families. It's time to bring this noncommunicable disease to the forefront and address its devastating impact.

Key Market Challenges

High Initial Costs

One of the most prominent challenges in the diaphragm pacing therapy system market is the high initial costs associated with these devices. The sophisticated technology and intricate surgical procedures required for implantation can result in substantial expenses for both healthcare facilities and patients. The cost may act as a deterrent, limiting access to those who may benefit from diaphragm pacing therapy.

Key Market Trends

Enhanced Device Technology

One of the most prominent trends in the diaphragm pacing therapy system market is the ongoing enhancement of device technology. Manufacturers are investing in research and development to create more advanced, efficient, and patient-friendly systems. This includes devices with improved battery life, wireless connectivity for remote monitoring, and more compact designs for enhanced comfort.

Key Market Players

• LUNGPACER MEDICAL INC.
• Avery Biomedical Devices, Inc.
• Synapse Biomedical Inc
• Astrotech Corp.
• AstraZeneca PLC
• Novartis AG
• Boehringer Ingelheim
• Respironics Ltd
• Johnson & Johnson (Actelion)
• PneumRx, LLC

Report Scope:

In this report, the Global Diaphragm Pacing Therapy System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diaphragm Pacing Therapy System Market, By Product:

• External Diaphragm Pacemaker
• Diaphragm Pacemaker

Diaphragm Pacing Therapy System Market, By Application:

• Spinal Cord Injury
• Amyotrophic Lateral Sclerosis
• Others

Diaphragm Pacing Therapy System Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diaphragm Pacing Therapy System Market.

Available Customizations:

Global Diaphragm Pacing Therapy System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diaphragm Pacing Therapy System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 5.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Diaphragm Pacing Therapy System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 6.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diaphragm Pacing Therapy System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Diaphragm Pacing Therapy System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Diaphragm Pacing Therapy System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Diaphragm Pacing Therapy System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 7.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Diaphragm Pacing Therapy System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Diaphragm Pacing Therapy System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. France Diaphragm Pacing Therapy System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Diaphragm Pacing Therapy System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Diaphragm Pacing Therapy System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Diaphragm Pacing Therapy System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 8.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Diaphragm Pacing Therapy System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. Japan Diaphragm Pacing Therapy System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. India Diaphragm Pacing Therapy System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. Australia Diaphragm Pacing Therapy System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. South Korea Diaphragm Pacing Therapy System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Diaphragm Pacing Therapy System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 9.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Diaphragm Pacing Therapy System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Diaphragm Pacing Therapy System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Diaphragm Pacing Therapy System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Diaphragm Pacing Therapy System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 10.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Diaphragm Pacing Therapy System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Diaphragm Pacing Therapy System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Diaphragm Pacing Therapy System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
  • 10.3.4. Kuwait Diaphragm Pacing Therapy System Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product
      • 10.3.4.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. LUNGPACER MEDICAL INC.
• 14.2. Avery Biomedical Devices, Inc.
• 14.3. Synapse Biomedical Inc
• 14.4. Astrotech Corp
• 14.5. AstraZeneca PLC
• 14.6. Novartis AG
• 14.7. Boehringer Ingelheim
• 14.8. Respironics Ltd
• 14.9. Johnson & Johnson (Actelion)
• 14.10. PneumRx, LLC

15. Strategic Recommendations

16. About Us & Disclaimer